Related Experiment Video
Updated: Aug 7, 2026
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Percutaneous interventional approaches to diseases of the aorta
1Louisiana State University Health Sciences Center, Shreveport, USA.
Insights
Endovascular grafts offer a less invasive treatment for aortic diseases, reducing mortality and complications compared to traditional open surgery. These new FDA-approved devices show promise for effective aortic aneurysm and dissection management.
Area of Science:
- Vascular Surgery
- Cardiovascular Medicine
- Medical Device Technology
Background:
- Aortic diseases, including aneurysms and dissections, are a significant cause of mortality, particularly in Western populations.
- Traditional surgical repair of aortic conditions involves high mortality and morbidity rates, especially in high-risk patients.
- Existing therapies have limitations, necessitating the development of less invasive treatment options.
Purpose of the Study:
- To evaluate the efficacy and safety of newly developed endovascular grafts for treating aortic diseases.
- To compare the outcomes of endovascular repair with traditional surgical methods.
- To highlight the benefits of a team approach in the deployment and care of patients undergoing endovascular aortic repair.
Main Methods:
- Development and FDA approval of new endovascular graft devices in the 1990s.
- Percutaneous delivery of endovascular grafts, avoiding traditional open surgical procedures.
- Team-based approach for optimal deployment and patient management.
Main Results:
- Initial clinical experience suggests endovascular devices provide effective treatment for aortic diseases.
- These endovascular techniques demonstrate a promise of low procedural complications.
- Endovascular repair offers a potentially safer alternative for high-risk surgical populations.
Conclusions:
- Endovascular aortic repair represents a significant advancement in managing aortic diseases.
- The new FDA-approved devices offer a promising alternative with reduced complications compared to open surgery.
- A collaborative, team-based approach is crucial for successful endovascular graft deployment and patient outcomes.
Abstract:
Diseases of the aorta are prevalent in the Western world. Pathophysiology is influenced by hypertension, atherosclerosis, and genetic factors. The rupture of an aortic aneurysm or the dissection of a hematoma into the aortic wall causes significant mortality in this country. Physicians have long wrestled with therapies to prevent this fatal natural history. It was not until the surgical insertion of aortic grafts in the 20th century that effective therapy was developed. However, surgical mortality and morbidity still remain quite significant in the higher risk population in which these procedures often must be performed. During the 1990s, techniques and devices have been developed which allow placement of endovascular grafts into the aorta percutaneously, without traditional surgery. Two recently FDA-approved devices require a team approach for optimal deployment and care. In the initial experience, these endovascular devices appear to offer the promise of effective treatment with low procedural complications.
Related Concept Videos
01:25Aortic Regurgitation III: Medical Management
01:27Coronary Artery Disease V: Interprofessional Care
01:27Peripheral Artery Disease III: Interprofessional Care
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
01:26Aneurysm III: Interprofessional Care